Merck & Co., Inc. (NYSE:MRK) Morgan Stanley 22nd Annual Global Healthcare Conference September 5, 2024 2:35 PM ET Company Participants Rob Davis - Chairman and CEO Dean Li - President of Merck Research Laboratories Conference Call Participants Terence Flynn - Morgan Stanley Terence Flynn Good afternoon, everybody. Thanks for joining us. Terence Flynn, US Biopharma Analyst at Morgan Stanley. Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.mor ...